Continue reading Closing Bell: Taking Them All to the Greeks (BP, ONXX, ROSE, QCOR, THQI)

Closing Bell: Taking Them All to the Greeks (BP, ONXX, ROSE, QCOR, THQI) originally appeared on BloggingStocks on Mon, 14 Jun 2010 16:00:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• Halozyme (NASDAQ: HALO) was initiated with a Buy rating and $14 target at Oppenheimer. The firm is positive on Halozyme's prospects for signing additional multi-product Enhanze deals in the next 12 months and the company's expanding internal pipeline.

• Oppenheimer also initiated shares of Rosetta Genomics (NASDAQ: ROSG) with a Buy rating and $11 target, as the firm is positive on Rosetta's intellectual property position in the emerging microRNA field related to the development and commercialization of research, diagnostic and therapeutic products, and other applications.

• Goldman Sachs resumed coverage of U.S. Steel Group (NYSE: X) with a Neutral rating.

• BioFuel Energy (NASDAQ: BIOF) was initiated with a Neutral rating at Cowen, as the firm sees a lack of catalysts until the company's plants under construction come on line in Q108...

• Brightpoint (NASDAQ: CELL) was initiated with an Outperform rating and $18 target at Credit Suisse.

• MasterCard (NYSE: MA) was initiated with a Market Perform rating at Wachovia on valuation.

• Citigroup initiated shares of Signature Bank (NASDAQ: SBNY) with a Buy rating and $39 target and shares of Discover Financial Services (NYSE: DFS) with a Sell rating and $24 target.

• Pacific Growth Equities started shares of Altair Nanotechnologies (NASDAQ: ALTI) with a Neutral rating.

Analyst initiations 7-24-07: CELL, DFS, MA and X originally appeared on BloggingStocks on Tue, 24 Jul 2007 11:11:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• Cowen believes AstraZeneca (NYSE: AZN) faces challenges from patent expirations, patent challenges, high-risk pipeline and value creation from deals, and initiated shares with a Neutral rating.

• Ametek (NYSE: AME) was initiated at Friedman Billings with an Outperform rating and $44 target, as the firm believes AME has turned into a collection of niche-oriented high-value-added manufacturers of precision instrumentation, resulting in a high-margin, high-return business with above average growth.

• InterNAP (NASDAQ: INAP) was initiated at Thomas Weisel with an Overweight rating, as the firm is positive on INAP's unique service offerings, VitalSteam acquisition opportunities, high growth customers, and improving collocation and bandwidth demand fundamentals.

• Cantor expects Rosetta Genomics (NASDAQ: ROSG) to launch the world's first microRNA-based cancer diagnostic in the second-half of 2008 with a market of $200 million, and initiated shares with a Buy rating and $15 target.

• Banc of America initiated shares of Spirit AeroSystems Holdings (NYSE: SPR) with a Buy rating and $42 target.

• Duke Energy (NYSE: DUK) was initiated with a Market Perform rating at BMO Capital.

• Merrill Lynch initiated shares of JMP Group (NYSE: JMP) with a Buy rating.

• UBS initiated shares of Itron (NASDAQ: ITRI) with a Neutral rating and $82 target.

Analyst initiations 6-28-07: AZN, DUK, JMP and SPR originally appeared on BloggingStocks on Thu, 28 Jun 2007 11:13:00 EST. Please see our terms for use of feeds.

Last December, over 100 stocks were featured in our Top Picks for 2007 report. Now, at mid-year, we turn to the 20 advisors whose picks showed the strongest gains to get an update on their previous picks, as well as a new favorite stock for the second half of the year.

Chris Mayer, editor of Capital & Crisis, chose Rosetta Resources Inc. (NASDAQ: ROSE) as his top pick for 2007. The stock rose 32%, as of June 1, 2007. Here is Chris's original recommendation for Rosetta and his new favorite stock for the rest of 2007.

Updating Rosetta, the advisor now says, "I continue to like ROSE, which should increase production greatly this year. The company is in good financial shape. It still has a relatively low-risk portfolio of drilling projects.

"I also feel good about the future of natural gas prices. In a world where we're draining the conventional natural gas wells at a fast rate, large fields of relatively untapped gas potential in the lower 48 are going to be worth a lot. Rosetta has that in its Rio Vista interests.

The company also keeps blowing away estimates. In the March quarter, earnings came in 33% better than analysts expected. In December, they beat the consensus by 24%. All of this and it still trades for a reasonable multiple -- only 14 times next year's (too low) estimate."

Top 20 advisors: Chris Mayer sees low risk with ROSE originally appeared on BloggingStocks on Tue, 26 Jun 2007 10:35:00 EST. Please see our terms for use of feeds.

Apple's 3rd Quarter Stumbling Blocks: the MacPro desktop and Japanese sales originally appeared on BloggingStocks on Thu, 19 Oct 2006 08:28:00 EST. Please see our terms for use of feeds.

Apple MacBook 'Times' gadget of the week originally appeared on BloggingStocks on Mon, 12 Jun 2006 17:34:00 EST. Please see our terms for use of feeds.